PathHunter® Panitumumab Bioassay Kit

The PathHunter® Panitumumab Bioassay kit provides an easy-to-use cell based assay to measure drug potency and detect neutralizing antibodies. This bioassay assesses EGF-induced dimerization of ErbB2 and EGFR receptors.

View bioassay qualification data.

 

Catalog #: 93-1051Y3-00093

$1,989.00$9,979.00


Inquire
Biological Information
Background Information:
The PathHunter® Panitumumab Bioassay kit provides an easy-to-use cell based assay to measure drug potency and detect neutralizing antibodies. This bioassay assesses EGF-induced dimerization of ErbB2 and EGFR receptors. This product uses EFC technology. The included cells overexpress ErbB2 target protein fused to PK alongside EGFR target protein fused to EA. Upon ligand-induced dimerization of ErbB2 and EGFR, detectable EFC signal is produced. This assay has been optimized and qualified with ‎Vectibix® (not supplied in the bioassay kit). ‎Vectibix® is a registered trademark of Amgen Inc. Bioassay kits are a convenient, ready-to-use format which contains all materials needed to run the assay, including single-use vials of cryopreserved cells, cell plating media, control agonist, detection reagent, and assay plates.
Target Class:
Kinase
Family:
Receptor Typosine Kinase (RTK): Growth Factor Receptor
Sub Family:
Protein Tyrosine
Accession Number:
NM_005228.3
Target Name:
EGFR/ErbB2
Target Aliases:
Epidermal growth factor receptor, ERBB, ERBB1, ERRP, HER1, NISBD2, PIG61, mENA
Target Species:
Human
Cell Background:
U2OS
Usage
Product Type:
Bioassay Kits
Application:
Potency; Commercial Release & Stability
Kit Components:
Storage Conditions:
Store in vapor phase of liquid nitrogen.
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Functional
Assay Measures:
SH2 Recruitment
Detection Method:
Chemiluminescence
Bioassay Data
Qualified With:
‎Vectibix®
Trademark Statement:
‎Vectibix® is a registered trademark of Amgen Inc.
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
PathHunter®

User Manuals & Protocols

70-383 PathHunter Panitumumab Bioassay Kit REV1 User Manual

View Document

Datasheets

93-1051Y3x Datasheet

View Document